These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5390904)

  • 1. [Effect of autoprothrombin C on the process of thrombinogenesis in normal and factor XII-deficient plasma].
    Strukova SM; Baskova IP; Suchkova SN
    Biokhimiia; 1969; 34(4):816-23. PubMed ID: 5390904
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the analogy of the action of thrombotropin and autoprothrombin C in some reactions of thrombinogenesis].
    Baskova IP; Strukova SM
    Biokhimiia; 1968; 33(1):137-41. PubMed ID: 5667963
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of phosphatidylserine in hemocoagulating action of factors V, VII and autoprothrombin C].
    Byshevskiĭ ASh; Mukhacheva IA; Lapuseva TM
    Biokhimiia; 1978 Jan; 43(1):78-82. PubMed ID: 623847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies regarding the effect of foreign-surface contact on the one-stage prothrombin time determination.
    Shanberge JN; Matsuoka T
    Thromb Diath Haemorrh; 1966 May; 15(3):442-50. PubMed ID: 5989030
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG; Cohen BM; Cohen E
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood coagulation. Role of Hageman protein (F-XII) and autoprothrombin II (F-IX?) in the activation of autoprothrombin 3 (F-X).
    Seegers WH; Grammens GL; McCoy LE
    Thromb Diath Haemorrh; 1970 Dec; 24(3):345-51. PubMed ID: 5533980
    [No Abstract]   [Full Text] [Related]  

  • 7. A study of antihaemophilic globulin (factor VIII) consumption.
    Sen NN; Denson KW; Biggs R
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):12-7. PubMed ID: 16955962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on syndromes of disseminated intravascular coagulation, in vitro and animal studies.
    Watanabe T
    Acta Med Biol (Niigata); 1970 Jul; 18(1):49-69. PubMed ID: 5484571
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance of factor XII (Hagemann's) in activation of the blood anticoagulation system].
    Kudriashov BA; Kalishevskaia TM; Baskova IP; Strukova SM; Kovaleva TN
    Vopr Med Khim; 1969; 15(5):486-94. PubMed ID: 5368086
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Initiation of blood coagulation].
    Saito H
    Rinsho Byori; 1985 Sep; 33(9):960-5. PubMed ID: 3878416
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of thorium dioxide upon blood clotting and platelets. I. In vitro studies.
    Hjort PF; McGehee WG; Rapaport SI
    Thromb Diath Haemorrh; 1966 Dec; 16(3):333-53. PubMed ID: 5996663
    [No Abstract]   [Full Text] [Related]  

  • 12. [The physiology of blood platelets].
    Lüscher EF
    Schweiz Med Wochenschr; 1968 Oct; 98(42):1629-35. PubMed ID: 5698340
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of factor IX in tissue thromboplastin induced coagulation.
    van den Besselaar AM; Ram IE; Alderkamp GH; Bertina RM
    Thromb Haemost; 1982 Aug; 48(1):54-8. PubMed ID: 6982540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vitamin K dependent blood clotting proteins (author's transl)].
    Kopeć M
    Postepy Biochem; 1980; 26(1):3-28. PubMed ID: 6994082
    [No Abstract]   [Full Text] [Related]  

  • 15. Factor XII and other hemostatic protein abnormalities in nephrotic syndrome patients.
    Thompson AR
    Thromb Haemost; 1982 Aug; 48(1):27-32. PubMed ID: 6813992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of changes in endogenous thrombin potential due to heritable disorders of coagulation.
    Ghosh K; Mota L; Shetty S; Kulkarni B
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):577-80. PubMed ID: 18685441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring hypocoagulant conditions in rat plasma: factors determining the endogenous thrombin potential of tissue factor-activated plasma.
    Nieuwenhuys CM; Feijge MA; Béguin S; Heemskerk JW
    Thromb Haemost; 2000 Dec; 84(6):1045-51. PubMed ID: 11154112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital deficiency of Hageman factor (clotting factor XII). Report on the first two families found in Switzerland.
    Baumann R; Straub PW
    Helv Med Acta; 1968 Nov; 34(4):313-26. PubMed ID: 5704616
    [No Abstract]   [Full Text] [Related]  

  • 19. [Change in plasma esterase activity during stimulation of the "2d anticoagulation system"].
    Baskova IP; Cherkesova DU; Orlova AS; Kudriashov BA
    Vopr Med Khim; 1974; 20(5):482-9. PubMed ID: 4456798
    [No Abstract]   [Full Text] [Related]  

  • 20. Differing mechanisms of thrombin generation in live haematological and solid cancer cells determined by calibrated automated thrombography.
    Adesanya MA; Maraveyas A; Madden L
    Blood Coagul Fibrinolysis; 2017 Dec; 28(8):602-611. PubMed ID: 28692431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.